How much does Oplusituzumab/Ointuzumab (Besponsa) cost?

Besponsa (Besponsa) is a drug used to treat a rare type of leukemia, Acute Lymphoblastic Leukemia (ALL). ALL is a malignant hematological disease that causes the production of a large number of immature lymphocytes in the bone marrow. These cells cannot function normally as the immune system and suppress the production of normal blood cells. Oxinutuzumab/Ointuzumab has been launched in China, but it is not included in medical insurance. The domestic price is 60,000 to 70,000 yuan, which is very expensive. There are only original drugs available abroad, mainly Pfizer's original drugs, and the price is more than 80,000 yuan (the price may fluctuate due to exchange rates).